289 related articles for article (PubMed ID: 34022485)
1. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD.
Chauhan A; Avti P; Shekhar N; Prajapat M; Sarma P; Bhattacharyya A; Kumar S; Kaur H; Prakash A; Medhi B
Comput Biol Med; 2021 Jul; 134():104495. PubMed ID: 34022485
[TBL] [Abstract][Full Text] [Related]
2. An insight into the simulation directed understanding of the mechanism in SARS CoV-2 N-CTD, dimer integrity, and RNA-binding: Identifying potential antiviral inhibitors.
Chauhan A; Avti PK; Shekhar N; Prajapat M; Sarma P; Sangwan N; Singh J; Bhattacharyya A; Kumar S; Kaur H; Sharma S; Prakash A; Medhi B
J Biomol Struct Dyn; 2022; 40(24):13912-13924. PubMed ID: 34751101
[TBL] [Abstract][Full Text] [Related]
3. Targeting SARS-CoV-2 nucleocapsid oligomerization: Insights from molecular docking and molecular dynamics simulations.
Ahamad S; Gupta D; Kumar V
J Biomol Struct Dyn; 2022 Apr; 40(6):2430-2443. PubMed ID: 33140703
[TBL] [Abstract][Full Text] [Related]
4. Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host.
Agrawal S; Pathak E; Mishra R; Mishra V; Parveen A; Mishra SK; Byadgi PS; Dubey SK; Chaudhary AK; Singh V; Chaurasia RN; Atri N
Comput Biol Med; 2022 Oct; 149():106049. PubMed ID: 36103744
[TBL] [Abstract][Full Text] [Related]
5. Structure-based virtual screening and molecular dynamics simulation of SARS-CoV-2 Guanine-N7 methyltransferase (nsp14) for identifying antiviral inhibitors against COVID-19.
Selvaraj C; Dinesh DC; Panwar U; Abhirami R; Boura E; Singh SK
J Biomol Struct Dyn; 2021 Aug; 39(13):4582-4593. PubMed ID: 32567979
[TBL] [Abstract][Full Text] [Related]
6. Computational basis of SARS-CoV 2 main protease inhibition: an insight from molecular dynamics simulation based findings.
Avti P; Chauhan A; Shekhar N; Prajapat M; Sarma P; Kaur H; Bhattacharyya A; Kumar S; Prakash A; Sharma S; Medhi B
J Biomol Struct Dyn; 2022; 40(19):8894-8904. PubMed ID: 33998950
[TBL] [Abstract][Full Text] [Related]
7. Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an
Amin M; Abbas G
J Biomol Struct Dyn; 2021 Aug; 39(12):4243-4255. PubMed ID: 32469265
[TBL] [Abstract][Full Text] [Related]
8. Structural interactions of phytoconstituent(s) from cinnamon, bay leaf, oregano, and parsley with SARS-CoV-2 nucleocapsid protein: A comparative assessment for development of potential antiviral nutraceuticals.
Husain I; Ahmad R; Siddiqui S; Chandra A; Misra A; Srivastava A; Ahamad T; Khan MF; Siddiqi Z; Trivedi A; Upadhyay S; Gupta A; Srivastava AN; Ahmad B; Mehrotra S; Kant S; Mahdi AA; Mahdi F
J Food Biochem; 2022 Oct; 46(10):e14262. PubMed ID: 35796388
[TBL] [Abstract][Full Text] [Related]
9. Patient-derived monoclonal antibodies to SARS-CoV-2 nucleocapsid protein N-terminal and C-terminal domains cross-react with their counterparts of SARS-CoV, but not other human betacoronaviruses.
Wen Y; Guo W; Min Y; Zhong K; Zhang X; Xing X; Tong Y; Pan Y; Hong W; Cai W; Yu L
Front Immunol; 2023; 14():1093709. PubMed ID: 36798118
[TBL] [Abstract][Full Text] [Related]
10. High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2.
Zinzula L; Basquin J; Bohn S; Beck F; Klumpe S; Pfeifer G; Nagy I; Bracher A; Hartl FU; Baumeister W
Biochem Biophys Res Commun; 2021 Jan; 538():54-62. PubMed ID: 33039147
[TBL] [Abstract][Full Text] [Related]
11.
Korn SM; Lambertz R; Fürtig B; Hengesbach M; Löhr F; Richter C; Schwalbe H; Weigand JE; Wöhnert J; Schlundt A
Biomol NMR Assign; 2021 Apr; 15(1):129-135. PubMed ID: 33270159
[TBL] [Abstract][Full Text] [Related]
12. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R
J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 nucleocapsid and Nsp3 binding: an in silico study.
Khan MT; Zeb MT; Ahsan H; Ahmed A; Ali A; Akhtar K; Malik SI; Cui Z; Ali S; Khan AS; Ahmad M; Wei DQ; Irfan M
Arch Microbiol; 2021 Jan; 203(1):59-66. PubMed ID: 32749662
[TBL] [Abstract][Full Text] [Related]
14. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain).
Sarma P; Shekhar N; Prajapat M; Avti P; Kaur H; Kumar S; Singh S; Kumar H; Prakash A; Dhibar DP; Medhi B
J Biomol Struct Dyn; 2021 May; 39(8):2724-2732. PubMed ID: 32266867
[TBL] [Abstract][Full Text] [Related]
15.
Rolta R; Yadav R; Salaria D; Trivedi S; Imran M; Sourirajan A; Baumler DJ; Dev K
J Biomol Struct Dyn; 2021 Nov; 39(18):7017-7034. PubMed ID: 32851912
[TBL] [Abstract][Full Text] [Related]
16. CTD of SARS-CoV-2 N protein is a cryptic domain for binding ATP and nucleic acid that interplay in modulating phase separation.
Dang M; Song J
Protein Sci; 2022 Feb; 31(2):345-356. PubMed ID: 34734665
[TBL] [Abstract][Full Text] [Related]
17. Phytocompound screening, antioxidant activity and molecular docking studies of pomegranate seed: a preventive approach for SARS-CoV-2 pathogenesis.
Ashfaq F; Barkat MA; Ahmad T; Hassan MZ; Ahmad R; Barkat H; Idreesh Khan M; Saad Alhodieb F; Asiri YI; Siddiqui S
Sci Rep; 2023 Oct; 13(1):17069. PubMed ID: 37816760
[TBL] [Abstract][Full Text] [Related]
18. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
19. Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein.
Zhou R; Zeng R; von Brunn A; Lei J
Mol Biomed; 2020; 1(1):2. PubMed ID: 34765991
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
